Clinical trial

Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)

NCT00212004

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2005-04-01

PhasePHASE4

Study timeline

Study start (actual)2005-04-01Date precision: month

Registry last updated2018-05-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitusunresolved

Myocardial Infarctionunresolved

Interventions

pioglitazoneDRUG · verified · RxNorm: pioglitazone

controlOTHER

Sponsors & collaborators

National Cerebral and Cardiovascular Center, Japanlead sponsor

Japan Heart Foundationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00212004 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.